Due Diligence Webinar – Kazia Therapeutics

Presenter – James Garner CEO & Managing Director – Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA) is an innovative oncology-focused biotechnology company based in Sydney, Australia. Kazia’s pipeline includes two clinical-stage drug development candidates and is working to develop therapies across a range of oncology indications.